| 產(chǎn)品名稱(chēng) |
Influenza A virus (H3N2) |
| 商品貨號(hào) |
B163164 |
| Classification |
Orthomyxoviridae, Alphainfluenzavirus |
| Deposited As |
Influenza A virus |
| Agent |
Influenza A virus (H3N2) |
| Strain |
A/Alice |
| Applications |
Influenza Research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
derived from MRC-2 (recombinant) |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
Resistant to serum inhibitors; carries strain A / England / 42 / 72 antigenicity (H(3)N(2)). |
| Effect on Host |
Hemagglutination activity |
| Recommended Host |
10 day chicken embryo, i.a. inoculation chicken embryo |
| Growth Conditions |
Temperature: 37°C Incubation: 1-4 days |
| Name of Depositor |
R.I.T. - Recherche et Industrie Therapeutiques |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
derived from MRC-2 (recombinant) |
| References |
Peetermans J. Live influenza virus vaccines and preparation thereof. US Patent 3,953,592 dated Apr 27 1976
|
